Turmeric has long been regarded as a super spice in Indian kitchens. It's the key component in curries, the go-to ...

The FDA’s recent approval of OZEMPIC highlights the expanding use of GLP-1 drugs beyond diabetes and weight management. Novo Nordisk’s blockbuster medication has gained another label expansion, now ...

An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...

A new study from Karolinska Institutet explores the connection between inflammatory bowel disease (IBD) and chronic kidney ...

Chia seeds nutrition is impressive, offering antioxidants, fiber, protein and other beneficial nutrients. Learn more about ...

Boxing champion Floyd Mayweather is entering the performance nutrition space by launching a new supplement line—101, or One ...

The deaths are also partly the result of medical successes: People are living longer, and more people are surviving heart ...

A new study found that a drug recently approved to treat type 2 diabetes and kidney disease in patients with additional ...

Vitamin D is crucial for bone health and the immune system, but excessive supplementation can lead to toxicity, causing ...

A change in Medicare coverage for some dialysis medications has left nursing homes and their patients receiving in-house treatment for kidney failure in a serious bind.

Observational data fill a knowledge gap in the absence of randomized trials comparing empagliflozin vs dapagliflozin in patients with type 2 diabetes.

These drugs, called GLP1-RAs (short for glucagon-like peptide-1 receptor agonists), have been found to reduce hospital visits ...